首页 | 本学科首页   官方微博 | 高级检索  
检索        


HTLV-1-host interactions on the development of adult T cell leukemia/lymphoma: virus and host gene expressions
Authors:Hanieh?Tarokhian  Hossein?Rahimi  Arman?Mosavat  Abbas?Shirdel  Houshang?Rafatpanah  Mohammad?Mehdi?Akbarin  Alireza?Bari  Samaneh?Ramezani  Email author" target="_blank">Seyed?Abdolrahim?RezaeeEmail author
Institution:1.Department of Immunology,School of Medicine, Kermanshah University of Medical Sciences,Kermanshah,Iran;2.Hematology and Oncology Department,Faculty of Medicine, Mashhad University of Medical Sciences,Mashhad,Iran;3.Blood Borne Infections Research Center, Academic Center for Education, Culture and Research (ACECR),Mashhad,Iran;4.Immunology Research center, Inflammation and Inflammatory Diseases Division,Mashhad University of Medical Sciences,Mashhad,Iran;5.Student Research Committee, Faculty of Medicine,Mashhad University of Medical Sciences,Mashhad,Iran
Abstract:

Background

Adult T-cell leukemia/lymphoma (ATLL) is a lymphoproliferative disorder of HTLV-1-host interactions in infected TCD4+ cells. In this study, the HTLV-1 proviral load (PVL) and HBZ as viral elements and AKT1, BAD, FOXP3, RORγt and IFNλ3 as the host factors were investigated.

Methods

The study was conducted in ATLLs, HTLV-1-associated myelopathy/tropical spastic paraparesis patients (HAM/TSPs) and HTLV-1-asympthomatic carriers (ACs). The DNA and mRNA from peripheral blood mononuclear cells were extracted for gene expression assessments via qRT-PCR, TaqMan assay, and then confirmed by western blotting.

Results

As it was expected, the HTLV-1-PVL were higher in ATLLs than ACs (P?=?0.002) and HAM/TSP (P?=?0.041). The HBZ expression in ATLL (101.76?±?61.3) was radically higher than in ACs (0.12?±?0.05) and HAM/TSP (0.01?±?0.1) (P?=?0.001). Furthermore, the AKT1 expression in ATLLs (13.52?±?4.78) was higher than ACs (1.17?±?0.27) (P?=?0.05) and HAM/TSPs (0.72?±?0.49) (P?=?0.008). However, BAD expression in ATLL was slightly higher than ACs and HAM/TSPs and not significant. The FOXP3 in ATLLs (41.02?±?24.2) was more than ACs (1.44?±?1) (P?=?0.007) and HAM/TSP (0.45?±?0.15) (P?=?0.01). However, RORγt in ATLLs (27.43?±?14.8) was higher than ACs (1.05?±?0.32) (P?=?0.02) but not HAM/TSPs. Finally, the IFNλ3 expression between ATLLs (31.92?±?26.02) and ACs (1.46?±?0.63) (P?=?0.01) and ACs and HAM/TSPs (680.62?±?674.6) (P?=?0.02) were statistically different, but not between ATLLs and HAM/TSPs.

Conclusions

The present and our previous study demonstrated that HTLV-1-PVL and HBZ and host AKT1 and Rad 51 are novel candidates for molecular targeting therapy of ATLL. However, high level of RORγt may inhibit Th1 response and complicated in ATLL progressions.
Keywords:
本文献已被 SpringerLink 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号